What You Should Know:
Funding to Improve the State of Precision Women’s Healthcare
Since its 2021 launch, Evvy has prioritized a data-driven approach to revolutionize women’s health. They utilize exclusive datasets related to female biomarkers, starting…
Continue Reading
Researchers at the Harvard Wyss Institute have developed a technique that lets clinicians to characterize and monitor melanoma. The system involves using a microneedle patch that can draw deep interstitial fluid into itself through…
Continue Reading
A new pancreatic cancer prediction model, utilizing routine blood markers, may reduce unnecessary biopsies by up to 6%. Researchers have validated this model, which assesses early-stage pancreatic cancer risk, and found it outperforms individual…
Continue Reading
By Shania Kennedy
September 13, 2023 – Researchers have developed and externally validated a prediction model to detect early-stage pancreatic cancer using routinely collected blood biomarkers, according to a recent study published in JAMA Network Open.
The…
Brainomix has partnered with the TIPAL trial group to run a sub-study that will assess the value of its e-Lung platform, an AI-powered image processing module.The TIPAL trial, a placebo-controlled, 52 week multi-centre study,…
Continue Reading
Human Papilloma Virus (HPV)-associated oropharyngeal squamous cell cancer (OPSCC) represents an OPSCC subgroup with an overall good prognosis with a rising incidence in Western countries. Multiple lines of evidence suggest that HPV-associated tumors are…
Continue Reading
Spinal Cord Stimulation (SCS) is a well-established therapy for treating chronic pain. However, perceived treatment response to SCS therapy may vary among people with chronic pain due to diverse needs and backgrounds. Patient Reported…
Continue Reading
What You Should Know:
– Sheba Medical Center, Israel’s largest medical center, today announced the deployment of a new accelerated, AI-powered cancer diagnostics research platform that can shorten diagnostic time from three weeks to minutes.
–…
Continue Reading
Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.Through the agreement, AstraZeneca will use Qureight’s proprietary analytics platform…
Continue Reading
The University of Edinburgh has joined the NEURii collaboration, which will explore the use of data and digital solutions to complement treatment options for people living with dementia. NEURii hopes to solve issues that…
Continue Reading
